Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Open in API
Filings indexed 951 across all filing types
Latest filing 2013-09-24 Regulatory Filings
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
FORM 8-K AMENDMENT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Amendment (8-K/A) filed with the SEC, which is a current report used to disclose unscheduled material events or corporate changes. The text indicates it is an amendment to a previously filed Form 8-K, providing omitted portions of agreements and clarifications. It does not contain financial statements or detailed financial performance data, nor is it a full annual or quarterly report. It is not a call transcript, earnings release, or any other specific report type. The document is a regulatory filing updating or correcting prior disclosures, fitting the category of Regulatory Filings (RNS). The document length is 4667 characters, which is relatively short and consistent with an amendment filing rather than a full report.
2013-09-24 English
CURRENT REPORT ON FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated September 19, 2013. The content focuses on the approval and grant of stock option awards to directors and officers, including details about the number of options granted and vesting schedules. This relates to compensatory arrangements for officers and directors, which is typically classified under management or board changes. The key section is Item 5.02, which specifically addresses departure, election, or appointment of directors or officers and compensatory arrangements. There is no indication of a full annual or quarterly report, earnings release, or other financial statements. The document is not a proxy statement or remuneration report but an announcement of management changes and compensation. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 3308 characters, which is consistent with a detailed announcement rather than a brief notice or a full report. Confidence is high given the clear SEC form type and content focus.
2013-09-24 English
OWNERSHIP DOCUMENT
Director's Dealing
2013-09-20 English
OWNERSHIP DOCUMENT
Director's Dealing
2013-09-20 English
OWNERSHIP DOCUMENT
Director's Dealing
2013-09-20 English
OWNERSHIP DOCUMENT
Director's Dealing
2013-09-20 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.